Valuation (0%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | -204.08 | N/A |
| PEG Ratio (TTM) | -2.04 | N/A |
| P/S Ratio (TTM) | N/A | N/A |
| P/B Ratio (TTM) | -10.32 | N/A |
| P/FCF Ratio (TTM) | -1,011,248.27 | N/A |
| Price to 5YR AVG Earnings Ratio | N/A | N/A |
| Price to 5YR AVG FCF Ratio | N/A | N/A |
Profitability (0%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | -0.61% | N/A |
| ROE (TTM) | -1.45% | N/A |
| Net Profit Margin (TTM) | N/A | N/A |
| ROIC 5YR AVG | N/A | N/A |
Growth (42%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 10,089,612.69% | 51,110.38% | N/A |
| Revenue | -50.00% | N/A | N/A |
| Net Income | 50,347,456.59% | 51,129.20% | N/A |
| Cash Flow | 297.36% | -164,701.49% | N/A |
Health (7%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 0.04 | N/A |
| Quick Ratio (TTM) | 0.04 | N/A |
| D/E Ratio (TTM) | N/A | N/A |
| Interest Coverage (TTM) | 2.78 | N/A |
| Piotroski F-Score | 2 | N/A |
| Altman Z-Score | N/A | N/A |
| LTL to 5YR AVG FCF | N/A | N/A |
| Shares Outstanding Growth 5YR AVG | N/A | N/A |